![]()
|
| MENU |
EfficacyIn the February 2003 RAND report "Ephedra and Ephedrine for Weight Loss and Athletic Performance Enchancement: Clinical Efficacy and Side Effects", limited evidence supporting health benefits was shown from ephedra use. This report reviewed the majority of recent clinical studies on the safety and efficacy of ephedra. The researchers found a modest but relatively consistent effect of short-term weight loss from ephedrine or ephedra-caffeine combination products. None of the studies, though, included treatment for more than 4 - 6 months or any follow-up after cessation of product use. Thus, no evidence on long-term weight loss is available. In addition, no evidence proved that ephedra enhanced athletic performance and very little evidence for this claim was shown for ephedrine. The Ephedra Working Group presented their report to the National Advisory Council for Complementary and Alternative Medicine on February 26, 2003. Their report was based on the RAND review and new publications since the preparation of that review. The following is a synopsis of the report: Efficacy for weight loss
|